Skip to main content
SpringerLink
Log in

Quinolones: pharmacology

  • Published:
Pharmaceutisch Weekblad Aims and scope Submit manuscript

Abstract

The quinolones are synthetic antibiotics chemically related to nalidixic acid. Since its introduction, several structural analogues have been synthesized. A fundamental breakthrough was the addition of a fluorine atom. The quinolones interfere with bacterial DNA transcription by inhibiting the enzyme DNA gyrase, that so far has only been found in bacteria. The nature of the activity of the quinolones on DNA gyrase makes it highly unlikely that resistance is carried on plasmids.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lesher GY, Froelich EJ, Gruett MD, Bailey JH, Brundage RP. 1,8-Naphthyridine derivatives. A new class of chemotherapeutic agents. J Med Pharm Chem 1962;55:1063–5.

    Google Scholar 

  2. Deitz WH, Bailey JH, Froelich EJ.In vitro antibacterial properties of nalidixic acid, a new drug active against Gram-negative organisms. Antimicrob Agents Chemother 1963:583–7.

  3. Turner FJ, Ringel SM, Martin JF, Storino PJ, Daly JM, Schwartz BS. Oxolinic acid, a new synthetic antimicrobial agent. 1.In vitro andin vivo activity. Antimicrob Agents Chemother 1967:475–9.

  4. Shimizu M, Nakamura S, Takase Y. Piromidic acid, a new antibacterial agent: antibacterial properties. Antimicrob Agents Chemother 1970:117–22.

  5. Wick WE, Preston DA, White WA, Gordee RS. Compound 64716, a new synthetic antibacterial agent. Antimicrob Agents Chemother 1973;4:415–20.

    Google Scholar 

  6. De Lajaudic P. L'acide pipémidic, nouvel antibactérien de synthese. J Pharmacol Clin 1974;1:155–71.

    Google Scholar 

  7. Inoue S, Ohue T, Yamagishi J, Nakamura S, Shimizu M. Mode of incomplete cross-resistance among pipemidic, piromidic and nalidixic acid. Antimicrob Agents Chemother 1978;14:240–5.

    Google Scholar 

  8. Rohlfing SR, Gerster JF, Kvam DC. Bioevaluation of the antibacterial flumequine for urinary tract use. Antimicrob Agents Chemother 1976;10:20–4.

    Google Scholar 

  9. Ito A, Hirai K, Inoue M, et al.In vitro activity of AM-715, a new nalidixic acid analog. Antimicrob Agents Chemother 1980;17:103–8.

    Google Scholar 

  10. Shimizu M, Takase Y, Nakamura S, et al. AT-2266 a new oral antipseudomonal agent. In: Nelson JD, Grassi C, eds. Current chemotherapy and infectious disease. Washington DC: American Society for Microbiology, 1980:451–4.

    Google Scholar 

  11. Goueffon Y, Montay G, Roquet F, Pesson M. A new synthetic antimicrobial agent: 1,4-dihydro-1-ethyl-6-fluoro-7-(4-methyl-1-piperazinyl)-4-oxoquinoline-3-carboxylic acid (RB 1589). CR Acad Sci 1981;292:37–40.

    Google Scholar 

  12. Sato K, Matsurra Y, Inoue M, et al.In vitro andin vivo activity of DL-8280, a new oxazine derivative. Antimicrob Agents Chemother 1982;22:548–53.

    Google Scholar 

  13. Wise R, Andrews JM, Edwards LJ.In vitro activity of Bay 09867, a new quinolone derivative compared with those of other antimicrobial agents. Antimicrob Agents Chemother 1983;23:559–64.

    Google Scholar 

  14. Bauernfeind A, Petermüller C.In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid. Eur J Clin Microbiol 1983;2:111–15.

    Google Scholar 

  15. Pohlod DJ, Saravolatz LD.In vitro susceptibilities of 393 recent clinical isolates to WIN 49375, cefotaxime, tobramycine and piperacillin. Antimicrob Agents Chemother 1984;25:377–9.

    Google Scholar 

  16. Goss WA, Deitz WH, Cook TM. Mechanism of action of nalidixic acid onEscherichia coli. 11. Inhibition of des-oxyribonucleic acid synthesis. J Bacteriol 1965;89:1068–74.

    Google Scholar 

  17. Winshell EB, Rosenkranz HS. Nalidixic acid and the metabolism ofEscherichia coli. J Bacteriol 1970;104:1168–75.

    Google Scholar 

  18. Bourguignon GJ, Levitt M, Sternglanz R. Studies on the mechanism of action of nalidixic acid. Antimicrob Agents Chemother 1973;4:479–86.

    Google Scholar 

  19. Geliert MK, Mizuchi M, O'Dea H, Nash HA. DNA gyrase: an enzyme that introduces superhelical turns in DNA. Proc Natl Acad Sci USA 1976;73:3872–6.

    Google Scholar 

  20. Geliert MK. DNA topoisomerases. Ann Rev Biochem 1981;50:879–910.

    Google Scholar 

  21. Sugino A, Peebles CL, Kreuzer KN, Cozzarelli NR. Mechanism of action of nalidixic acid: purification ofEscherichia coli nal A gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme. Proc Natl Acad Sci USA 1977;74:4767–71.

    Google Scholar 

  22. Crumplin GC, Kenwright M, Hirst T. Investigations into the mechanism of action of the antibacterial agent norfloxacin. J Antimicrob Chemother 1984;13(suppl B):9–23.

    Google Scholar 

  23. Drlica K, Snyder M. SuperhelicalEscherichia coli DNA: relaxation by coumermycin. J Mol Biol 1978;120:145–54.

    Google Scholar 

  24. Sugino A, Higgins NP, Brown PO, Peebles CL, Cozzarelli NR. Energy coupling in DNA gyrase and the mechanism of action of novobiocin. Proc Natl Acad Sci USA 1978;75:4838–42.

    Google Scholar 

  25. Engle E, Maives S, Drlica K. Differential effects of antibiotics affecting gyrase. J Bacteriol 1982;149:92–8.

    Google Scholar 

  26. Shen L, Tricarico K, Pernet AG. Mechanism of inhibition of DNA gyrase by quinolone antibacterial agents: the target of the drug is DNA. In: 24th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington DC, October 8–10, 1984. Washington CD: American Society for Microbiology. 1985: abstract 978.

    Google Scholar 

  27. Hane MW, Wood TH.Escherichia coli K-12 mutants resistant to nalidixic acid: genetic mapping and dominance studies. J Bacteriol 1969;99:238–41.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Diagnostic Microbiology Laboratory, University Hospital St. Rafaël, B-3000, Leuven, Belgium

    L. Verbist

Authors
  1. L. Verbist
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Verbist, L. Quinolones: pharmacology. Pharmaceutisch Weekblad Scientific Edition 8, 22–25 (1986). https://doi.org/10.1007/BF01975474

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01975474

Key words

Search

Navigation